WaveDancer
Open
$1.53
Prev. Close
$1.53
High
$1.53
Low
$1.52
Market Snapshot
$22.49M
-2.4
-1.52
$108K
17
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. The company is headquartered in Kenmore, New York and currently employs 17 full-time employees. The firm's BNA Platform and Evoke System are Class II medical devices, which were cleared by FDA for commercialization. The firm's FDA-510(k) cleared Evoke System, commercially deployed as the Evoke System, is in active use over 85 clinical sites in the United States. The firm has developed Firefly Platform, a vertically integrated hardware, software, and data infrastructure that captures standardized electroencephalographic (EEG) and event-related potential (ERP) assessments at the point of care, analyzes that data through its proprietary analytics engine, and delivers structured, clinician-ready reports back to the provider, all within a single seamless workflow. Its proprietary analytics engine analyzes raw EEG and ERP signals across captured dimensions and compares each patient’s electrophysiological profile to a reference dataset.
Firefly Neuroscience, Inc. is an artificial intelligence (AI) technology company, which engages in developing neuroscientific solutions for mental illnesses and neurological disorders. The company is headquartered in Kenmore, New York and currently employs 17 full-time employees. The firm's BNA Platform and Evoke System are Class II medical devices, which were cleared by FDA for commercialization. The firm's FDA-510(k) cleared Evoke System, commercially deployed as the Evoke System, is in active use over 85 clinical sites in the United States. The firm has developed Firefly Platform, a vertically integrated hardware, software, and data infrastructure that captures standardized electroencephalographic (EEG) and event-related potential (ERP) assessments at the point of care, analyzes that data through its proprietary analytics engine, and delivers structured, clinician-ready reports back to the provider, all within a single seamless workflow. Its proprietary analytics engine analyzes raw EEG and ERP signals across captured dimensions and compares each patient’s electrophysiological profile to a reference dataset.
Recently from Cashu
It seems that there is no content provided for me to summarize. Please share the text you’d like me to work with!
Please provide the text you’d like me to summarize.
It appears you haven't provided the content you'd like summarized. Please share it, and I'll create a title for you!
Please provide the content you'd like me to summarize.
WaveDancer Collaborates on ADHD Research to Transform Diagnosis and Treatment Strategies
Transforming ADHD Diagnosis and Treatment through Neural Biomarkers In a significant advancement within the field of neurodevelopmental disorders, WaveDancer's recent collaboration with Firefly Center…
Firefly's EEG Research Advances Understanding and Treatment of ADHD
Innovative Advances in Understanding ADHD: Firefly's EEG Research Firefly is at the forefront of research into Attention-Deficit/Hyperactivity Disorder (ADHD), employing advanced EEG technologies such…